Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine

Thumbnail
Göster/Aç
Tarih
2012
Yazar
Erguven, M.
Bilir, A.
Yazihan, N.
Korkmaz, S.
Aktas, E.
Ovalioglu, C.
Dundar, T.
Seyithanoglu, H.
Üst veri
Tüm öğe kaydını göster
Özet
The purpose of the present study was to overcome resistance to imatinib (IM) by combining it with roscovitine (ROSC) and to investigate whether or not midkine (MK) had an effect on this combination in the treatment of glioblastoma (GBL). Human T98 GBL cel
Bağlantı
https://doi.org/10.3892/ol.2011.434
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1559
Koleksiyonlar